Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
P 2 (2)
P 3 (1)

Trial Status

Unknown7
Completed7
Not Yet Recruiting2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06922916Not Yet Recruiting

Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study

NCT06090370Not ApplicableCompletedPrimary

Reducing Silica Exposure Among Brick Kiln Workers in Nepal

NCT06403800RecruitingPrimary

Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern Tanzania

NCT06011785Early Phase 1Not Yet RecruitingPrimary

Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil

NCT04205708CompletedPrimary

Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma

NCT05538299UnknownPrimary

Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials

NCT05546944UnknownPrimary

The SHIELD Study-silicosis

NCT05402176UnknownPrimary

The SHIELD Whole Lung Lavage Study

NCT05118256Phase 2UnknownPrimary

Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis

NCT04161014Phase 2Unknown

The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial

NCT02430259Phase 3CompletedPrimary

Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention

NCT02794701CompletedPrimary

Comprehensive Risk Assessment of People With Silicosis: A Population-based Study

NCT00005280Completed

Specialized Center of Research in Occupational and Immunologic Lung Disease

NCT01725971CompletedPrimary

Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis

NCT01977131Phase 1CompletedPrimary

Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis

NCT01338064UnknownPrimary

Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)

NCT01329003UnknownPrimary

DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)

Showing all 17 trials

Research Network

Activity Timeline